Vyvanse denied by insurance? Appeal and win.
A denial of Vyvanse is the start of a process, not the final word. Because Vyvanse is a Schedule II controlled substance with an available generic, plans almost always route it through prior authorization, step therapy, or a push toward generic lisdexamfetamine before they pay for the brand. What flips these denials is a clearly documented diagnosis, a record of the generics or alternatives already tried, and a letter of medical necessity that maps directly to the plan's own coverage criteria.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Vyvanse (lisdexamfetamine) is FDA-approved to treat attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older, and to treat moderate-to-severe binge eating disorder (BED) in adults. It is the only medication FDA-approved for binge eating disorder. It is not approved or appropriate for weight loss, and its safety and effectiveness for obesity have not been established.
Why Vyvanse gets denied
- Step therapy: the plan requires you to try and fail a generic or lower-tier stimulant, such as generic lisdexamfetamine, methylphenidate, or mixed amphetamine salts, before it will cover Vyvanse.
- Brand-over-generic denial: with generic lisdexamfetamine available since 2023, plans often deny brand Vyvanse as non-preferred and direct you to the generic unless a clinical reason for the brand is documented.
- Prior authorization criteria not met: the submitted records do not document the diagnosis, prior medication trials, or monitoring the plan requires for a Schedule II stimulant.
- Diagnosis or age/indication limits: the request lacks a confirmed ADHD or moderate-to-severe binge eating disorder diagnosis, or falls outside the plan's age and quantity limits.
What a winning appeal includes
- A documented diagnosis with the correct ICD-10 code (for example F90.x for ADHD or F50.81 for binge eating disorder) and the clinical findings that support it.
- A clear history of prior therapies tried, including generic lisdexamfetamine or other stimulants, with dates, doses, and the specific failure, intolerance, or adverse reaction for each.
- A letter of medical necessity that quotes the plan's own published criteria and maps each requirement to the patient's chart point by point.
- Supporting documentation such as a validated rating scale, treatment notes, cardiovascular and blood pressure assessment, and the prescriber's rationale for Vyvanse specifically.
How we approach the appeal
First identify the type of denial: a non-formulary or brand-versus-generic decision is appealed as a formulary or tier exception, while a clinical denial is appealed as a prior authorization or medical necessity appeal. Pull the plan's published Vyvanse or stimulant coverage policy and quote its exact criteria, then answer each requirement with the patient's documented diagnosis, prior trials, and the medical reason the generic or preferred alternative is inadequate. If the written appeal is upheld, request a peer-to-peer review so the prescriber can speak directly with the plan's medical director, and escalate to external review if needed.
Vyvanse appeal letter template
Copy this Vyvanse appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns Central nervous system stimulant (prodrug amphetamine) denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Vyvanse denial I am appealing the denial of Vyvanse (lisdexamfetamine dimesylate). I request that the denial be overturned and Vyvanse approved. 1. The denial. [Insurer] denied Vyvanse stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Vyvanse is medically necessary for my condition. First identify the type of denial: a non-formulary or brand-versus-generic decision is appealed as a formulary or tier exception, while a clinical denial is appealed as a prior authorization or medical necessity appeal. Pull the plan's published Vyvanse or stimulant coverage policy and quote its exact criteria, then answer each requirement with the patient's documented diagnosis, prior trials, and the medical reason the generic or preferred alternative is inadequate. If the written appeal is upheld, request a peer-to-peer review so the prescriber can speak directly with the plan's medical director, and escalate to external review if needed. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Vyvanse within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days of the denial.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Vyvanse denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
Why does my insurer want me to use generic lisdexamfetamine instead of Vyvanse?
Generic lisdexamfetamine became available in 2023 and costs the plan less, so many formularies now treat brand Vyvanse as non-preferred and prefer the generic. If the generic works for you, it is the same active ingredient. If you have a documented reason the brand is medically necessary, such as a failure or adverse reaction with the generic, your prescriber can submit that with a brand exception request.
Does Vyvanse always need prior authorization?
Often, yes. Vyvanse is a Schedule II controlled substance, and most plans require prior authorization for stimulants. Approval usually depends on a documented diagnosis, prior medication trials, and confirmation that the request meets the plan's published criteria. Quantity limits are also common.
Can I appeal if my plan denied Vyvanse for binge eating disorder?
Yes. Vyvanse is the only FDA-approved medication for moderate-to-severe binge eating disorder in adults, so a strong appeal documents that specific diagnosis with its ICD-10 code, the severity, and any prior treatments. Map this to the plan's criteria in a letter of medical necessity, and request a peer-to-peer review if the written appeal is upheld.
Vyvanse denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.